| Date Checked | 2025-12-21 23:37:48 |
|---|---|
| Graham Number | (PB)87.60 vs (PE)67.49 |
| Over / Under Value Percentage | 119.75% vs 142.70% |
| Dividend Yield | 2.47% |
| Dividend Date | 2025-12-09 |
| Symbol | JNJ |
| AssetType | Common Stock |
| Name | Johnson & Johnson |
| Description | Johnson & Johnson (JNJ) is a leading American multinational corporation established in 1886, specializing in medical devices, pharmaceuticals, and consumer health products. With a strong emphasis on innovation and quality, J&J significantly influences the global healthcare sector and is consistently ranked among the world's most valuable companies. As a key component of the Dow Jones Industrial Average and holding a prestigious AAA credit rating, Johnson & Johnson showcases exceptional financial stability and operational excellence. Positioned 36th on the Fortune 500 list, the company is strategically poised for sustainable growth while continuing to deliver trusted health solutions globally. |
| CIK | 200406 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NJ, UNITED STATES, 08933 |
| OfficialSite | https://www.jnj.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 487834059000 |
| EBITDA | 31922000000 |
| PERatio | 19.56 |
| PEGRatio | 1.109 |
| BookValue | 32.95 |
| DividendPerShare | 5.08 |
| EPS | 10.35 |
| RevenuePerShareTTM | 38.28 |
| ProfitMargin | 0.273 |
| OperatingMarginTTM | 0.302 |
| ReturnOnAssetsTTM | 0.0826 |
| ReturnOnEquityTTM | 0.336 |
| RevenueTTM | 92148998000 |
| GrossProfitTTM | 62988001000 |
| DilutedEPSTTM | 10.35 |
| QuarterlyEarningsGrowthYOY | 0.91 |
| QuarterlyRevenueGrowthYOY | 0.068 |
| AnalystTargetPrice | 202.54 |
| AnalystRatingStrongBuy | 4 |
| AnalystRatingBuy | 9 |
| AnalystRatingHold | 11 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | 19.56 |
| ForwardPE | 17.86 |
| PriceToSalesRatioTTM | 5.29 |
| PriceToBookRatio | 6.24 |
| EVToRevenue | 5.66 |
| EVToEBITDA | 13.12 |
| Beta | 0.358 |
| 52WeekHigh | 207.81 |
| 52WeekLow | 136.5 |
| 50DayMovingAverage | 192.49 |
| 200DayMovingAverage | 169.84 |
| SharesOutstanding | 2409295000 |
| SharesFloat | 2405513000 |
| PercentInsiders | 0.058 |
| PercentInstitutions | 75.127 |
| ExDividendDate | 2025-11-25 |
| dateChecked | 2025-12-21 23:37:48 |
| fresh | 1 |